KORU Medical Systems Return on Equity (ROE) Growth & History (KRMD)
KORU Medical Systems's return on equity was −15.58% for fiscal 2025.
View full KORU Medical Systems company overviewKORU Medical Systems annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −15.58% | +17.06 pp |
| 2024 | 2024-12-31 | −32.64% | +20.53 pp |
| 2023 | 2023-12-31 | −53.18% | −27.64 pp |
| 2022 | 2022-12-31 | −25.54% | −12.98 pp |
| 2021 | 2021-12-31 | −12.56% | −7.44 pp |
| 2020 | 2020-12-31 | −5.11% | −10.70 pp |
| 2019 | 2019-12-31 | 5.59% | −5.36 pp |
| 2018 | 2018-12-31 | 10.95% | −1.67 pp |
| 2017 | 2017-12-31 | 12.62% | — |
| 2016 | 2017-02-28 | −7.76% | −19.45 pp |
| 2015 | 2016-02-29 | 11.69% | −1.45 pp |
| 2014 | 2015-02-28 | 13.14% | −1.60 pp |
| 2013 | 2014-02-28 | 14.73% | −3.62 pp |
| 2012 | 2013-02-28 | 18.36% | −8.70 pp |
| 2011 | 2012-02-29 | 27.06% | — |
KORU Medical Systems quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.44% | +2.70 pp |
| Q1 2026 | 2026-03-31 | −4.75% | +2.28 pp |
| Q4 2025 | 2025-12-31 | −2.91% | +6.13 pp |
| Q3 2025 | 2025-09-30 | −4.72% | +3.96 pp |
| Q2 2025 | 2025-06-30 | −1.26% | +3.97 pp |
| Q1 2025 | 2025-03-31 | −7.03% | +2.78 pp |
| Q4 2024 | 2024-12-31 | −9.04% | +22.21 pp |
| Q3 2024 | 2024-09-30 | −8.68% | −3.75 pp |
| Q2 2024 | 2024-06-30 | −5.23% | +3.39 pp |
| Q1 2024 | 2024-03-31 | −9.81% | −1.92 pp |
| Q4 2023 | 2023-12-31 | −31.25% | −25.05 pp |
| Q3 2023 | 2023-09-30 | −4.93% | −1.16 pp |
| Q2 2023 | 2023-06-30 | −8.62% | +0.04 pp |
| Q1 2023 | 2023-03-31 | −7.89% | −0.77 pp |
| Q4 2022 | 2022-12-31 | −6.19% | −3.28 pp |
| Q3 2022 | 2022-09-30 | −3.76% | −0.81 pp |
| Q2 2022 | 2022-06-30 | −8.67% | −5.67 pp |
| Q1 2022 | 2022-03-31 | −7.12% | −3.67 pp |
| Q4 2021 | 2021-12-31 | −2.92% | −0.72 pp |
| Q3 2021 | 2021-09-30 | −2.95% | −3.58 pp |
| Q2 2021 | 2021-06-30 | −3.00% | +1.19 pp |
| Q1 2021 | 2021-03-31 | −3.45% | −7.30 pp |
| Q4 2020 | 2020-12-31 | −2.19% | −1.47 pp |
| Q3 2020 | 2020-09-30 | 0.63% | −5.73 pp |
| Q2 2020 | 2020-06-30 | −4.19% | −5.03 pp |
| Q1 2020 | 2020-03-31 | 3.85% | +4.79 pp |
| Q4 2019 | 2019-12-31 | −0.72% | +3.20 pp |
| Q3 2019 | 2019-09-30 | 6.35% | +2.02 pp |
| Q2 2019 | 2019-06-30 | 0.84% | −4.82 pp |
| Q1 2019 | 2019-03-31 | −0.94% | −6.05 pp |
| Q4 2018 | 2018-12-31 | −3.92% | −8.77 pp |
| Q3 2018 | 2018-09-30 | 4.34% | +0.63 pp |
| Q2 2018 | 2018-06-30 | 5.66% | +3.49 pp |
| Q1 2018 | 2018-03-31 | 5.11% | — |
| Q4 2017 | 2017-12-31 | 4.85% | — |
| Q2 2017 | 2017-09-30 | 3.70% | — |
| Q1 2017 · Jun 30 | 2017-06-30 | 2.17% | — |
| Q3 2016 | 2016-11-30 | −1.54% | −4.05 pp |
| Q2 2016 · Aug 31 | 2016-08-31 | −1.20% | −6.45 pp |
| Q1 2016 · May 31 | 2016-05-31 | −3.32% | −2.28 pp |
| Q4 2015 | 2016-02-29 | 4.96% | +0.08 pp |
| Q3 2015 | 2015-11-30 | 2.51% | +0.95 pp |
| Q2 2015 | 2015-08-31 | 5.25% | +1.65 pp |
| Q1 2015 | 2015-05-31 | −1.04% | −4.02 pp |
| Q4 2014 | 2015-02-28 | 4.88% | −2.68 pp |
| Q3 2014 | 2014-11-30 | 1.56% | −1.89 pp |
| Q2 2014 | 2014-08-31 | 3.60% | +1.60 pp |
| Q1 2014 | 2014-05-31 | 2.99% | +1.33 pp |
| Q4 2013 | 2014-02-28 | 7.56% | +2.13 pp |
| Q3 2013 | 2013-11-30 | 3.45% | +2.08 pp |
| Q2 2013 | 2013-08-31 | 2.00% | −7.19 pp |
| Q1 2013 | 2013-05-31 | 1.66% | −0.85 pp |
| Q4 2012 | 2013-02-28 | 5.43% | −3.84 pp |
| Q3 2012 | 2012-11-30 | 1.37% | −4.30 pp |
| Q2 2012 | 2012-08-31 | 9.19% | +4.97 pp |
| Q1 2012 | 2012-05-31 | 2.51% | — |
| Q4 2011 | 2012-02-29 | 9.27% | — |
| Q3 2011 | 2011-11-30 | 5.68% | — |
| Q2 2011 | 2011-08-31 | 4.22% | — |
KORU Medical Systems return on equity trends
Over the last five fiscal years, KORU Medical Systems's return on equity decreased from −5.11% to −15.58%, a change of −10.47 percentage points. The latest reported quarter, Q2 2026, shows 1.44%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review KORU Medical Systems source filings ↗